Tag: generic drug surveillance
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Bioequivalence Studies: How to Meet FDA Requirements for Generic Drug Approval
Apr, 13 2026
Hydration Plans to Protect Kidneys from Nephrotoxic Medications
Nov, 21 2025
Malaria in the United States: Current Risks, Stats, and Prevention
Oct, 3 2025
Asian Generic Pharmaceutical Markets: Analyzing India, China, and Emerging Hubs
Apr, 27 2026
Opioid-Induced Constipation: How to Prevent and Treat It With Prescription Options
Dec, 19 2025